Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Baues, Christian; Marnitz, Simone; Lukas, Peter et al.
Role of radiotherapy in Hodgkin lymphomaONKOLOGIE. Bd. 28. H. 10. 2022 S. 872-878
Tilch, Marie-Kristin; Robak, Tadeusz; Ghiggi, Chiara et al.
Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed LymphomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Bd. 22. H. 4. 2022 S. 270-275
Stelzner, Sigmar; Ruppert, Reinhard; Kube, Rainer et al.
Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI-Results from OCUM trialEUROPEAN JOURNAL OF RADIOLOGY. Bd. 147. 2022
Feiten, Stefan; Scholl, Isabelle; Duennebacke, Jan et al.
Shared decision-making in routine breast cancer care in Germany-A cross-sectional studyPSYCHO-ONCOLOGY. Bd. 31. H. 7. 2022 S. 1120-1126
Feil, Charlotte; Staib, Frank; Berger, Martin R. et al.
Sniffer dogs can identify lung cancer patients from breath and urine samplesONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 153-153
Roick, J.; Singer, S.
Social Inequalities in the Participation after Laryngeal Cancer and Associations with mental HealthGESUNDHEITSWESEN. Bd. 84. H. 08/09. 2022 S. 724-724
Schroeder, Christina; Tang, Hongjian; Windisch, Paul et al.
Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic ReviewCANCERS. Bd. 14. H. 3. 2022
Bostel, Tilman; Bremer, Michael
Stereotactic radiotherapy of primary liver tumors and liver metastasesONKOLOGE. Bd. 28. H. 4. 2022 S. 318-325
Tilch, Marie-Kristin; Schranz, Melanie; Moringlane, Alice et al.
Struggling with extensive informed consent procedures for cancer trials-is there even a benefit for the patients?SUPPORTIVE CARE IN CANCER. Bd. 30. H. 8. 2022 S. 6593-6602
Reinisch, Mattea; Untch, Michael; Mahlberg, Rolf et al.
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference-Substudy of the randomised phase III GAIN-2 studyBREAST. Bd. 66. 2022 S. 110-117